Skip to main content

Medical Hypotheses's replacement?

A linkurl:former member;https://www.the-scientist.com/blog/display/57440/ of the editorial board at linkurl:Medical Hypotheses;https://www.elsevier.com/wps/find/journaldescription.cws_home/623059/description#description has started a similar publication called linkurl:Hypotheses in the Life Sciences,;https://www.hy-ls.org/ following Elsevier's decision to institute a more traditional peer review process at the once editorially reviewed journal. Image: flicker/linkurl:meviola;https://www.flickr.com/

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
A linkurl:former member;https://www.the-scientist.com/blog/display/57440/ of the editorial board at linkurl:Medical Hypotheses;https://www.elsevier.com/wps/find/journaldescription.cws_home/623059/description#description has started a similar publication called linkurl:Hypotheses in the Life Sciences,;https://www.hy-ls.org/ following Elsevier's decision to institute a more traditional peer review process at the once editorially reviewed journal.
Image: flicker/linkurl:meviola;https://www.flickr.com/photos/69659670@N00/
This fall, Hypotheses in the Life Sciences will begin publishing papers that introduce new ideas in biology that "advance or challenge scientific thinking," according to a press release from the journal's publisher, the University of Buckingham Press. The papers will be chosen primarily with the guidance of the editorial board, which includes Medical Hypotheses's linkurl:recently fired;https://www.the-scientist.com/blog/display/57204/ editor-in-chief linkurl:Bruce Charlton,;https://www.buckingham.ac.uk/publicity/dofe/charlton.html with occasional outside advice from the peer-review community for topics that are beyond the technical expertise of the board. "We're trying to steer a middle course [between] completely autonomous editorial choice and a more conventional peer review system," said the journal's founding editor linkurl:William Bains.;https://www.williambains.co.uk/ "What a journal of this sort can provide is a certain amount of scientific quality control, but without attempting to be definitely authoritative and without some of the restrictions that come from conventional peer review." Bains served on the editorial board at Medical Hypotheses, as well as editor-in-chief of a short-lived spinoff called Bioscience Hypotheses, which Elsevier discontinued in late 2009 due to financial reasons, Bains said. Now, Bains is recreating that outlet for life science researchers to voice new -- and potentially radical -- ideas about their work. Medical Hypotheses came linkurl:under fire;https://www.the-scientist.com/blog/display/57121/ when it decided to publish a controversial paper by AIDS denialist Peter Duesburg last summer. In response, its publisher, Elsevier, instituted a more traditional peer-review process, and terminated Charlton's contract. Charlton lends his full support to the new venture, and hopes "to 'repay' [Bains] with the same kind of good advice and support that he used to provide for me when I edited Medical Hypotheses," Charlton told The Scientist in an email.
**__Related stories:__***linkurl:New editor for Medical Hypotheses;https://www.the-scientist.com/blog/display/57508/
[24th June 2010]*linkurl:Q&A: Medical Hypotheses 2.0;https://www.the-scientist.com/blog/display/57440/
[19th May 2010]*linkurl:Journal editor facing axe;https://www.the-scientist.com/blog/display/57204/
[8th March 2010]*linkurl:Radical journal gathers support;https://www.the-scientist.com/blog/display/57190/
[ 26th February 2010]*linkurl:Radical journal's fate at risk;https://www.the-scientist.com/blog/display/57121/
[27th January 2010]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays